Is ConvaTec Group Plc (CNVVY) a Buy, Sell, or Hold?
OTC : CNVVY
ConvaTec Group Plc
$11.684 USD
$0.12 (0.99%)
- Volume
- 300
- Average Volume
- 29.45K
- Market Capitalization
- $5.71B
- P/E Ratio
- 33.65
- Dividend Yield
- 2.45%
- Price Target
- Year High
- $14.09
- Year Low
- $10.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.78
- Current Ratio
- $1.53
Company Overview
OTC
Jonathan Peter Mason
Medical - Instruments & Supplies
Healthcare
CNVVY
10910
GB
USD
Liquidity Metrics
1.00
1.53
0.85
0.12
0.78
Sales & Valuation
$2.44B
2.34
3.79
16.60
0.71
Profitability
$0.34
$175.41M
7.17%
9.42%
10.53%
4.64%
P/E Metrics
33.65
-5.59
-5.59
Analyst Price Target & Rating
3/5
6 Analysts
%
Poll Results
No votes yet today — be the first to share your view!
About ConvaTec Group Plc (OTC:CNVVY) Stock
ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company offers advanced wound care and skin protection solutions, tailored for the effective management of both acute and chronic wounds arising from diverse conditions such as diabetes, immobility, venous disease, traumatic injuries, burns, or complications following surgery. Furthermore, ConvaTec provides comprehensive ostomy care, including specialized devices, accessories, and support services for individuals living with a stoma, often necessitated by conditions like colorectal or bladder cancer, inflammatory bowel disease, obesity, among other medical reasons. Its product portfolio also extends to continence ... and critical care. This encompasses intermittent urinary catheters and solutions for managing bladder control issues linked to spinal cord injuries, multiple sclerosis, spina bifida, and various other urological disorders. Additionally, the firm supplies medical devices and products specifically designed for use in intensive care units (ICUs) and broader hospital settings. ConvaTec develops sophisticated systems for handling acute fecal incontinence, as well as for precise monitoring of urine production output and intra-abdominal pressure. A diverse array of disposable medical devices is also provided, featuring wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen/aerosol therapy, suction handles and tubing, gastroenterology tubes, and securement devices. The company is also a supplier of disposable infusion sets to manufacturers of insulin pumps for diabetic patients, and similar sets for pumps employed in continuous infusion treatments for other medical conditions. ConvaTec serves a broad spectrum of clients, including healthcare providers, patients, and other manufacturers. Its products reach both hospital and home healthcare markets, distributed through direct sales, as well as via distributors and wholesalers, targeting pharmacies, hospitals, and various acute and post-acute healthcare service providers. Established in 1978, the company's corporate headquarters are located in Reading, United Kingdom.
2026-05-21 10:50:47
Convatec Group PLC (CNVVY) ConvaTec Group PLC, 4 Months Period Ending/ Trading Statement Call Transcript
Medical product maker Convatec warns of higher cost from Iran War
2026-05-21 07:56:24
British medical products maker Convatec on Thursday posted slower organic revenue growth for the first four months of 2026 and its CEO warned of higher costs in 2027 due to the Iran conflict, sending shares 8% lower.
ConvaTec falls despite backing outlook
2026-05-21 03:46:58
Shares in ConvaTec Group PLC (LSE:CTEC) led the FTSE 100 fallers on Thursday, dropping almost 5% despite saying it had made a "good start" to the year and was on track to hit 2026 guidance. The maker of medical products for managing chronic conditions reported organic revenue growth of 4.8% in the first four months of 2026, excluding its InnovaMatrix wound-care product.
2026-05-05 10:11:00
LONDON--(BUSINESS WIRE)--Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from 6–8 May 2026. Convatec's industry-leading Advanced Wound Care innovation is supported by compelling new data from randomised controlled trials (RCTs) and real-world s.
Frequently Asked Questions
-
What is the current ConvaTec Group Plc (CNVVY) stock price?
-
ConvaTec Group Plc(OTC:CNVVY) stock price is $11.684 in the last trading session. During the trading session, CNVVY stock reached the peak price of $14.093 while $10.45 was the lowest point it dropped to. The percentage change in CNVVY stock occurred in the recent session was 0.99% while the dollar amount for the price change in CNVVY stock was $0.12.
-
CNVVY's industry and sector of operation?
-
The OTC listed CNVVY is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of CNVVY?
-
Mark Jassey | President and Chief Operating Officer of Continence Care & Home Services Group
Fiona Victoria Ryder | Chief Financial Officer & Director
Peter J. Byloos | President of Advanced Wound Care
Erik Zimmer | VP, GM of Ostomy Care Franchise & President for the Ostomy Care Franchise
Fiona Adam | Consultant -
How many employees does CNVVY have?
-
Number of CNVVY employees currently stands at 10910. CNVVY operates from 20 Eastbourne Terrace, London, GL W2 6LG, GB.
-
Link for CNVVY official website?
-
Official Website of CNVVY is: https://www.convatecgroup.com
-
How do I contact CNVVY?
-
CNVVY could be contacted at phone #44 11 8952 8100 and can also be accessed through its website. CNVVY operates from 20 Eastbourne Terrace, London, GL W2 6LG, GB.
-
How many shares of CNVVY are traded daily?
-
The average number of CNVVY shares traded daily for last 3 months was 29.45K.
-
What is the market cap of CNVVY currently?
-
The market value of CNVVY currently stands at $5.71B with its latest stock price at $11.684